Late diagnosis of COL4A1 mutation and problematic vascular risk factor management

European Neurology

Volumn 72, Issue , 2014, Pages 150-152

  Magnin, Eloi ^a,d   Ayrignac, Xavier ^b   Berger, Eric ^a   Mine, Manuele ^c   Tournier Lasserve, Elisabeth ^c   Labauge, Pierre ^b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA 1; GLYCINE; UNCLASSIFIED DRUG; WARFARIN; ANTICOAGULANT AGENT; COL4A1 PROTEIN, HUMAN; BROMIDE; COLLAGEN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATAXIA; ATTENTION DEFICIT DISORDER; BINDING SITE; BRAIN HEMORRHAGE; CASE REPORT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DYSARTHRIA; DYSPHAGIA; EXECUTIVE FUNCTION; EXON; FOLLOW UP; FRONTAL LOBE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEADACHE; HUMAN; LEUKOENCEPHALOPATHY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; TRANSIENT GLOBAL AMNESIA; VASCULAR COGNITIVE IMPAIRMENT; WHITE MATTER LESION; COGNITION DISORDERS; COMPLICATION; DELAYED DIAGNOSIS; FAMILY HEALTH; GENETICS; MUTATION; VASCULAR DISEASES; BRAIN HEMATOMA; CARDIOVASCULAR RISK; COL4A1 GENE; CONSULTATION; EXOME; FATIGUE; GENE; HEART ATRIUM FIBRILLATION; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTHYROIDISM; INTRAOCULAR HEMORRHAGE; LETTER; NEUROLOGIC EXAMINATION; PHENOTYPE; PRIORITY JOURNAL;

AGED; ANTICOAGULANTS; COGNITION DISORDERS; COLLAGEN TYPE IV; DELAYED DIAGNOSIS; FAMILY HEALTH; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; VASCULAR DISEASES;

EID: 84906599074     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000360532     Document Type: Article

References (9)

1. Vahedi K, Alamowich S: Clinical spectrum of type IV (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 2011; 24: 63-68.
2. Ferreira S, Vanholsbeeck G, Chopard G, Pitard A, Tio G, Vandel P, et al: Normes comparatives de la batterie de tests neuropsychologiques RAPID pour les sujets âgés de 50 à 89 ans. Rev Neurol (Paris) 2010; 166: 606-614.
3. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-1142.
4. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H: Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689.
5. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL, Wardlaw JM, Al-Shahi Salman R: Improving interrater agreement about microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 2009; 40: 94-99.
6. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol 2003; 2: 89-98.
7. Plaisier E, Chen Z, Gekeler F, Benhassine S, Dahan K, Marro B, Alamowitch S, Paques M, Ronco P: Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A 2010; 152A:2550-2555.
8. Weng YC, Sonni A, Labelle-Dumais C, de Leau M, Kauffman WB, Jeanne M, Biffi A, Greenberg SM, Rosand J, Gould DB: COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012; 71: 470-477.
9. Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, Bousser MG, Heutink P, Miner JH, Tournier-Lasserve E, John SW: Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006; 354: 1489-1496.